Your browser doesn't support javascript.
loading
An integrated genetic analysis of epileptogenic brain malformed lesions.
Fujita, Atsushi; Kato, Mitsuhiro; Sugano, Hidenori; Iimura, Yasushi; Suzuki, Hiroharu; Tohyama, Jun; Fukuda, Masafumi; Ito, Yosuke; Baba, Shimpei; Okanishi, Tohru; Enoki, Hideo; Fujimoto, Ayataka; Yamamoto, Akiyo; Kawamura, Kentaro; Kato, Shinsuke; Honda, Ryoko; Ono, Tomonori; Shiraishi, Hideaki; Egawa, Kiyoshi; Shirai, Kentaro; Yamamoto, Shinji; Hayakawa, Itaru; Kawawaki, Hisashi; Saida, Ken; Tsuchida, Naomi; Uchiyama, Yuri; Hamanaka, Kohei; Miyatake, Satoko; Mizuguchi, Takeshi; Nakashima, Mitsuko; Saitsu, Hirotomo; Miyake, Noriko; Kakita, Akiyoshi; Matsumoto, Naomichi.
Affiliation
  • Fujita A; Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Kato M; Department of Pediatrics, Showa University School of Medicine, Tokyo, 142-8666, Japan.
  • Sugano H; Department of Neurosurgery, Epilepsy Center, Juntendo University, Tokyo, 113-8421, Japan.
  • Iimura Y; Department of Neurosurgery, Epilepsy Center, Juntendo University, Tokyo, 113-8421, Japan.
  • Suzuki H; Department of Neurosurgery, Epilepsy Center, Juntendo University, Tokyo, 113-8421, Japan.
  • Tohyama J; Department of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, 950-2085, Japan.
  • Fukuda M; Department of Functional Neurosurgery, Epilepsy Center, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, 950-2085, Japan.
  • Ito Y; Department of Functional Neurosurgery, Epilepsy Center, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, 950-2085, Japan.
  • Baba S; Department of Child Neurology, Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, 430-8558, Japan.
  • Okanishi T; Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, 683-8503, Japan.
  • Enoki H; Department of Pediatrics, Kawasaki Medical School, Kurashiki, 701-0192, Japan.
  • Fujimoto A; Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, 430-8558, Japan.
  • Yamamoto A; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, 060-8543, Japan.
  • Kawamura K; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, 060-8543, Japan.
  • Kato S; Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, 060-8543, Japan.
  • Honda R; Department of Pediatrics, National Hospital Organization Nagasaki Medical Center, Omura, 856-8562, Japan.
  • Ono T; Epilepsy Center, National Hospital Organization Nagasaki Medical Center, Omura, 856-8562, Japan.
  • Shiraishi H; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, 060-8638, Japan.
  • Egawa K; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, 060-8638, Japan.
  • Shirai K; Department of Pediatrics, Tsuchiura Kyodo General Hospital, Tsuchiura, 300-0028, Japan.
  • Yamamoto S; Department of Neurosurgery, Tsuchiura Kyodo General Hospital, Tsuchiura, 300-0028, Japan.
  • Hayakawa I; Division of Neurology, National Center for Child Health and Development, Tokyo, 157-8535, Japan.
  • Kawawaki H; Department of Pediatric Neurology, Children's Medical Center, Osaka City General Hospital, Osaka, 534-0021, Japan.
  • Saida K; Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Tsuchida N; Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Uchiyama Y; Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, 236-0004, Japan.
  • Hamanaka K; Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Miyatake S; Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, 236-0004, Japan.
  • Mizuguchi T; Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Nakashima M; Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Saitsu H; Department of Clinical Genetics, Yokohama City University Hospital, Yokohama, 236-0004, Japan.
  • Miyake N; Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Kakita A; Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Matsumoto N; Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Acta Neuropathol Commun ; 11(1): 33, 2023 03 02.
Article in En | MEDLINE | ID: mdl-36864519
ABSTRACT
Focal cortical dysplasia is the most common malformation during cortical development, sometimes excised by epilepsy surgery and often caused by somatic variants of the mTOR pathway genes. In this study, we performed a genetic analysis of epileptogenic brain malformed lesions from 64 patients with focal cortical dysplasia, hemimegalencephy, brain tumors, or hippocampal sclerosis. Targeted sequencing, whole-exome sequencing, and single nucleotide polymorphism microarray detected four germline and 35 somatic variants, comprising three copy number variants and 36 single nucleotide variants and indels in 37 patients. One of the somatic variants in focal cortical dysplasia type IIB was an in-frame deletion in MTOR, in which only gain-of-function missense variants have been reported. In focal cortical dysplasia type I, somatic variants of MAP2K1 and PTPN11 involved in the RAS/MAPK pathway were detected. The in-frame deletions of MTOR and MAP2K1 in this study resulted in the activation of the mTOR pathway in transiently transfected cells. In addition, the PTPN11 missense variant tended to elongate activation of the mTOR or RAS/MAPK pathway, depending on culture conditions. We demonstrate that epileptogenic brain malformed lesions except for focal cortical dysplasia type II arose from somatic variants of diverse genes but were eventually linked to the mTOR pathway.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Malformations of Cortical Development, Group I / Focal Cortical Dysplasia / Nervous System Malformations Limits: Humans Language: En Journal: Acta Neuropathol Commun Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Malformations of Cortical Development, Group I / Focal Cortical Dysplasia / Nervous System Malformations Limits: Humans Language: En Journal: Acta Neuropathol Commun Year: 2023 Document type: Article Affiliation country:
...